These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10927075)

  • 1. Lack of effect of topical finasteride suggests an endocrine role for dihydrotestosterone.
    Price TM; Allen S; Pegram GV
    Fertil Steril; 2000 Aug; 74(2):414-5. PubMed ID: 10927075
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of finasteride in idiopathic hirsutism.
    Faloia E; Filipponi S; Mancini V; Di Marco S; Mantero F
    J Endocrinol Invest; 1998 Nov; 21(10):694-8. PubMed ID: 9854686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism.
    Moghetti P; Castello R; Magnani CM; Tosi F; Negri C; Armanini D; Bellotti G; Muggeo M
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1115-21. PubMed ID: 7962284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical finasteride therapy in hirsutism.
    Rodriguez-Rigau LJ
    Endocr Pract; 2001; 7(1):64-5. PubMed ID: 11250772
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up.
    Castello R; Tosi F; Perrone F; Negri C; Muggeo M; Moghetti P
    Fertil Steril; 1996 Nov; 66(5):734-40. PubMed ID: 8893676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of finasteride 1 mg in the treatment of androgenetic alopecia in men.
    Olsen EA
    Exp Dermatol; 1999 Aug; 8(4):302-3. PubMed ID: 10439233
    [No Abstract]   [Full Text] [Related]  

  • 7. Finasteride inhibits 5 alpha-reductase activity in human dermal fibroblasts: prediction of its therapeutic application in androgen-related skin diseases.
    Nguyen QH; Chen T; Wang X; Chen Y; Chien P
    Int J Dermatol; 1995 Oct; 34(10):720-5. PubMed ID: 8537164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of a 12-month treatment with finasteride in idiophathic and polycystic ovary syndrome-associated hirsutism.
    Petrone A; Civitillo RM; Galante L; Giannotti F; D'Antò V; Rippa G; Tolino A
    Clin Exp Obstet Gynecol; 1999; 26(3-4):213-6. PubMed ID: 10668160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism.
    Lakryc EM; Motta EL; Soares JM; Haidar MA; de Lima GR; Baracat EC
    Gynecol Endocrinol; 2003 Feb; 17(1):57-63. PubMed ID: 12724020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose (2.5 mg/day) finasteride treatment in hirsutism.
    Bayram F; Müderris I; Güven M; Ozçelik B; Keleştimur F
    Gynecol Endocrinol; 2003 Oct; 17(5):419-22. PubMed ID: 14710591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study.
    Tartagni MV; Alrasheed H; Damiani GR; Montagnani M; De Salvia MA; De Pergola G; Tartagni M; Loverro G
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):161-5. PubMed ID: 24559619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
    Spinucci G; Pasquali R
    Clin Ter; 1996 Jun; 147(6):305-15. PubMed ID: 8925640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism.
    Ciotta L; Cianci A; Calogero AE; Palumbo MA; Marletta E; Sciuto A; Palumbo G
    Fertil Steril; 1995 Aug; 64(2):299-306. PubMed ID: 7615107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
    Sahin Y; Dilber S; Keleştimur F
    Fertil Steril; 2001 Mar; 75(3):496-500. PubMed ID: 11239530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH).
    Denti L; Pasolini G; Cortellini P; Sanfelici L; Benedetti R; Cecchetti A; Ferretti S; Banchini A; Ablondi F; Valenti G
    J Endocrinol Invest; 1999; 22(10 Suppl):70-1. PubMed ID: 10727053
    [No Abstract]   [Full Text] [Related]  

  • 16. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
    Walsh DS; Dunn CL; James WD
    Arch Dermatol; 1995 Dec; 131(12):1373-5. PubMed ID: 7492124
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
    Schwartz JI; Van Hecken A; De Schepper PJ; De Lepeleire I; Lasseter KC; Shamblen EC; Winchell GA; Constanzer ML; Chavez CM; Wang DZ; Ebel DL; Justice SJ; Gertz BJ
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2942-7. PubMed ID: 8768856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finasteride cream in hirsutism.
    Lucas KJ
    Endocr Pract; 2001; 7(1):5-10. PubMed ID: 11250761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finasteride--an update and review.
    Cather JC; Lane D; Heaphy MR; Nelson BR
    Cutis; 1999 Sep; 64(3):167-72. PubMed ID: 10500917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.